Seprify - Switzerland
Industrial biotech/functional ingredients for food and personal care, with expanding applications in nutraceuticals
EDERA Lab brings a strong understanding of how startups operate and have supported our PR and visibility efforts with a structured and consistent approach. Their work helped us communicate our progress more effectively and maintain visibility with relevant audiences.
“
— Dr Lukas Schertel, Co-founder & CEO at Seprify
The Challenge
As Seprify progressed towards its Series A, the company entered a pivotal phase: translating technical innovation into tangible commercial traction while preparing for a significant fundraising milestone.
Operating across food and personal care ingredients, Seprify faced the typical complexity of B2B industrial markets, where long sales cycles, validation requirements, and risk-averse buyers demand more than just strong technology.
The opportunity was to:
Strengthen credibility with industrial partners and distributors
Clearly communicate the value of its technology to both commercial and investor audiences
Align commercial progress with a compelling fundraising narrative
Demonstrate traction across multiple application areas
The Solution
EDERA Lab supported Seprify as an embedded marketing partner, working across both commercial enablement and fundraising communications.
This included:
Strategic Narrative Development
Translating Seprify’s technology into a clear, differentiated positioning tailored to both buyers and investorsCommercial Enablement
Developing targeted content and marketing assets to support business development efforts, specifically designed for industries with long sales cycles and high purchase barriersPartnership Visibility
Amplifying key commercial milestones, including distribution agreements in food and personal care, and application expansion into nutraceuticals, to reinforce traction and market validationFundraising Support
Structuring and amplifying communications around the Series A round, ensuring consistency between commercial momentum and investor messagingMulti-channel Execution
Activating visibility across PR, owned channels, and digital platforms to build sustained presence across key audiences
Seprify strengthened its position as a commercially advancing and credible player in the functional ingredients space.
Outcomes included:
Successful distribution agreements with partners across food and personal care
Increased visibility of commercial traction, supporting both partner engagement, inbound interest and investor confidence - reflected in 44 pieces of earned media coverage and a 50.5M estimated reach in the first 6 months, as well as 100% organic LinkedIn growth with an 11.1% engagement rate, reaching a high-quality audience including 25.6% senior decision-makers
A well-positioned Series A raise, backed by leading investors including the Inter IKEA Fund - supported by 70+ pieces of earned media coverage across investor, tech, and industry media
By aligning marketing closely with both business development and fundraising, Seprify was able to accelerate its path to commercialisation while strengthening its positioning with key stakeholders.
